Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development.


Visit us at our upcomming events.

Contact us

Interview with Toxys CEO Giel Hendriks and cover spread in TerugbliQ – the year report from Innovation Quarter

No Comments

Leave a reply